Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Background

Hepatoblastoma (HB) is the most common primary malignant tumor of the liver in young children. The aim of this study is to identify the diagnostic and prognostic values of serum exosomal miR-21 in Chinese patients with HB.

Methods

We retrospectively reviewed 32 children with HB. The expressions of miR-21 were detected by real-time PCR. The comparison of diagnostic performance of plasmatic, exosomal miR-21 and AFP levels was measured using the Area Under ROC Curve.

Results

For patients in HB group, miR-21 concentration was significantly higher in the exosomes compared with the exosome-depleted supernatants and whole plasma. Expression of miR-21 was significantly higher in patients with HB compared with control group in both plasma and exosomes. With respect to the diagnosis of patients with HB, exosomal miR-21 was significantly more accurate compared with the Alpha-fetoprotein levels. Moreover, exosomal miR-21 was an independent predictor of Even-free survival for patients with HB.

Conclusions

In this study, we found that expression of miR-21 was significantly higher in patients with HB compared with control group in both plasma and exosomes, and we confirmed that exosomal miR-21 could be defined as a diagnostic and prognostic biomarker for patients with HB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J (2004) Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42:74–83

    Article  CAS  PubMed  Google Scholar 

  2. Tiao GM, Bobey N, Allen S, Nieves N, Alonso M, Bucuvalas J, Wells R, Ryckman F (2005) The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146:204–211

    Article  PubMed  Google Scholar 

  3. Horton JD, Lee S, Brown SR, Bader J, Meier DE (2009) Survival trends in children with hepatoblastoma. Pediatr Surg Int 25:407–412

    Article  PubMed  Google Scholar 

  4. Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall’Igna P, Otte JB, De Camargo B, Zsiros J, Zimmermann A, Aronson D, Childs M, Scopinaro M, Morland B, Plaschkes J, Czauderna P, Perilongo G (2012) Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer 48:1543–1549

    Article  PubMed  Google Scholar 

  5. Qiao GL, Li L, Cheng W, Ge J, Zhang Z, Wei Y (2014) Predictors of survival after resection of children with hepatoblastoma: a single Asian center experience. Eur J Surg Oncol 40:1533–1539

    Article  PubMed  Google Scholar 

  6. Naidu S, Magee P, Garofalo M (2015) MiRNA-based therapeutic intervention of cancer. J Hematol Oncol 8:68

    Article  PubMed  PubMed Central  Google Scholar 

  7. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940–948

    Article  CAS  PubMed  Google Scholar 

  8. Kharaziha P, Ceder S, Li Q, Panaretakis T (2012) Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta 1826:103–111

    CAS  PubMed  Google Scholar 

  9. Nonaka R, Nishimura J, Kagawa Y, Osawa H, Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, Takemasa I, Mizushima T, Okuzaki D, Yamamoto H, Doki Y, Mori M (2014) Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncol Rep 32:2354–2358

    CAS  PubMed  Google Scholar 

  10. Qin Y, Dang X, Li W, Ma Q (2013) miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer. Oncol Res 21(6):353–363

    Article  PubMed  Google Scholar 

  11. Leichter AL, Purcell RV, Sullivan MJ, Eccles MR, Chatterjee A (2015) Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples. Gigascience 4:54

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7:e30679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W (2015) Exosomes in cancer: small particle, big player. J Hematol Oncol 8:83

    Article  PubMed  PubMed Central  Google Scholar 

  14. Challagundla KB, Fanini F, Vannini I, Wise P, Murtadha M, Malinconico L, Cimmino A, Fabbri M (2014) MicroRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn 14:565–574

    Article  CAS  PubMed  Google Scholar 

  15. Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, Kanto T, Doki Y, Mori M (2012) Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56:167–175

    Article  CAS  PubMed  Google Scholar 

  16. Sheng WZ, Chen YS, Tu CT, He J, Zhang B, Gao WD (2016) MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer. World J Gastroenterol 22:5532–5539

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, Zhang H, Li DG, Wang YY, Wu HY, She Y, Liu QF, Fan FY, Meng AM (2011) Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 72(1):92–99

    Article  PubMed  Google Scholar 

  18. Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335

    CAS  PubMed  Google Scholar 

  19. Dr C (1972) Regression models and life-tables. J R Stat Soc B 34:187–220

    Google Scholar 

  20. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A (2002) Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94:1111–1120

    Article  PubMed  Google Scholar 

  21. Czauderna P, Otte JB, Roebuck DJ, von Schweinitz D, Plaschkes J (2006) Surgical treatment of hepatoblastoma in children. Pediatr Radiol 36:187–191

    Article  PubMed  Google Scholar 

  22. Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, Burger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95:172–182

    Article  PubMed  Google Scholar 

  23. Raj DA, Fiume I, Capasso G, Pocsfalvi G (2012) A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int 81:1263–1272

    Article  CAS  PubMed  Google Scholar 

  24. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17:879–887

    Article  CAS  PubMed  Google Scholar 

  25. Cairo S, Wang Y, de Reynies A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA (2010) Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 107:20471–20476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, Goga A, Balakrishnan A, Semeraro M, Gresh L, Pontoglio M, Strick-Marchand H, Levillayer F, Nouet Y, Rickman D, Gauthier F, Branchereau S, Brugieres L, Laithier V, Bouvier R, Boman F, Basso G, Michiels JF, Hofman P, Arbez-Gindre F, Jouan H, Rousselet-Chapeau MC, Berrebi D, Marcellin L, Plenat F, Zachar D, Joubert M, Selves J, Pasquier D, Bioulac-Sage P, Grotzer M, Childs M, Fabre M, Buendia MA (2008) Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14:471–484

    Article  CAS  PubMed  Google Scholar 

  27. Gyugos M, Lendvai G, Kenessey I, Schlachter K, Halasz J, Nagy P, Garami M, Jakab Z, Schaff Z, Kiss A (2014) MicroRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Arch 464:419–427

    Article  CAS  PubMed  Google Scholar 

  28. von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Burger D, Erttmann R, Harms D, Mildenberger H (1997) Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 33:1243–1249

    Article  Google Scholar 

  29. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH (2009) Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 53:1016–1022

    Article  PubMed  PubMed Central  Google Scholar 

  30. De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, Pritchard J, Shafford L, Zsiros J, Czaudzerna P, Perilongo G (2008) Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 44:545–550

    Article  PubMed  Google Scholar 

  31. von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D (1997) Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 74:593–599

    Article  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Medical Affairs, The General Hospital of the PLA Rocket Force, Beijing, China

      Wanbo Liu

    2. Department of General Surgery, The General Hospital of the PLA Rocket Force, Beijing, China

      Sheng Chen

    3. Center for Disease Prevention and Control of Rocket Force, No. 109, Beiqing Road, Haidian distinct, Beijing, 100032, China

      Bing Liu

    Authors
    1. Wanbo Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Sheng Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Bing Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Bing Liu.

    Ethics declarations

    Conflict of interest

    The authors who have taken part in this study declared that they have nothing to disclose regarding funding or conflict of interest with respect to this manuscript.

    Additional information

    W. Liu and S. Chen contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Liu, W., Chen, S. & Liu, B. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int 32, 1059–1065 (2016). https://doi.org/10.1007/s00383-016-3960-8

    Download citation

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00383-016-3960-8

    Keywords

    Search

    Navigation